ORCID as entered in ROS

Select Publications
2023, 'A novel practical class using crickets to demonstrate the pharmacological actions of drugs for third year neuropharmacology students', presented at ANS, 04 December 2023 - 07 December 2023
,2023, 'Patient’s experience of a psychiatric, alcohol and non-prescription drug assessment (PANDA) unit', Sydney, presented at ASCEPT, Sydney, 20 November 2023 - 23 November 2023
,2022, 'The trends and opinions of Australian clinicians on the use of antihyperglycemic agents in heart failure patients', Queenstown, New Zealand, presented at ASCEPT-PAGANZ, Queenstown, New Zealand, 25 November 2022 - 29 November 2019
,2021, 'Matters close to the heart: adaptation of a tacrolimus model to inform therapeutic drug monitoring using the PRIOR approach', Virtual, presented at American Conference on Pharmacometrics, Virtual, 08 November 2021 - 12 November 2021
,2021, 'Matters close to the heart: adaptation of a tacrolimus model to inform therapeutic drug monitoring using the PRIOR approach', Virtual, presented at IATDMCT, Virtual, 19 September 2021 - 22 September 2021
,2021, 'Matters close to the heart: adaptation of a tacrolimus model to inform therapeutic drug monitoring using the PRIOR approach', Virtual, presented at Population Approach Group Europe, Virtual, 02 September 2021 - 07 September 2021
,2020, 'Predictive performance of population pharmacokinetic models for tacrolimus in lung transplant recipients', Virtual, presented at ASCEPT, Virtual, 29 November 2020 - 02 December 2020
,2020, 'A step forward in patient safety - understanding barriers to correct intravenous medication administrations', Virtual, presented at ASCEPT, Virtual, 29 November 2020 - 02 December 2020
,2020, 'External evaluation of population pharmacokinetic models of tacrolimus in adult heart transplant recipients', presented at Pharmacometrics Japan, 22 January 2020 - 23 January 2020
,2019, 'Accuracy of documented administration times for intravenous antimicrobial drugs', Queenstown, New Zealand, presented at ASCEPT-PAGANZ, Queenstown, New Zealand, 25 November 2019 - 29 November 2019
,2019, 'Barriers and facilitators to user acceptance of a pilot therapeutic drug monitoring advisory service for vancomycin', Queenstown, New Zealand, presented at ASCEPT-PAGANZ, Queenstown, New Zealand, 25 November 2019 - 29 November 2019
,2019, 'External evaluation of published population pharmacokinetic models of tacrolimus in adult heart transplant recipients', Queenstown, New Zealand, presented at ASCEPT-PAGANZ, Queenstown, New Zealand, 25 November 2019 - 29 November 2019
,2019, 'Population pharmacokinetic models of tacrolimus in adult transplant recipients: a systematic review', Queenstown, New Zealand, presented at ASCEPT-PAGANZ, Queenstown, New Zealand, 25 November 2019 - 29 November 2019
,2019, 'Designing a therapeutic drug monitoring (TDM) advisory service for vancomycin: identifying barriers and facilitators to service implementation', Darwin, Australia, presented at ASID, Darwin, Australia, 16 May 2019 - 18 May 2019
,2019, 'Predictive performance of a commercial Bayesian forecasting program in estimating vancomycin drug exposure', Washington DC, USA, presented at American Society for Clinical Pharmacology and Therapeutics, Washington DC, USA, 14 March 2019 - 16 March 2019
,2018, 'Comparison of vancomycin area-under-the-curve using one and two-compartment pharmacokinetic models', Adelaide, Australia, presented at ASCEPT, Adelaide, Australia, 27 November 2018 - 30 November 2018
,2018, 'Predictive performance of tacrolimus precision dosing software', Adelaide, Australia, presented at ASCEPT, Adelaide, Australia, 27 November 2018 - 30 November 2018
,2018, 'Tacrolimus Dosing and Monitoring in Lung Transplant Patients', Adelaide, Australia, presented at ASCEPT, Adelaide, Australia, 27 November 2018 - 30 November 2018
,2018, 'Tacrolimus dosing and monitoring: a retrospective cohort study', Adelaide, Australia, presented at ASCEPT, Adelaide, Australia, 27 November 2018 - 30 November 2018
,2018, 'Understanding amikacin, are we hitting the mark?', Brisbane, Australia, presented at IATDMCT, Brisbane, Australia, 16 September 2018 - 19 September 2018
,2017, 'A Multicentre Open-Label Pharmacokinetic-Pharmacodynamic Study of Febuxostat in Patients with Chronic Gout', Brisbane, Australia, presented at APSA-ASCEPT, Brisbane, Australia, 05 December 2017 - 08 December 2017
,2017, 'A time and motion study of phlebotomists’ work', Brisbane, Australia, presented at APSA-ASCEPT, Brisbane, Australia, 05 December 2017 - 08 December 2017
,2017, 'Education for vancomycin – what works?', Brisbane, Australia, presented at APSA-ASCEPT, Brisbane, Australia, 05 December 2017 - 08 December 2017
,2017, 'The Safety and Pharmacokinetics of Metformin in Heart Failure', Brisbane, Australia, presented at APSA-ASCEPT, Brisbane, Australia, 05 December 2017 - 08 December 2017
,2017, 'The Safety of Metformin in Haemodiafiltration', Brisbane, Australia, presented at APSA-ASCEPT, Brisbane, Australia, 05 December 2017 - 08 December 2017
,2017, 'Therapeutic drug monitoring of voriconazole', Brisbane, Australia, presented at APSA-ASCEPT, Brisbane, Australia, 05 December 2017 - 08 December 2017
,2016, 'Exploring the barriers and facilitators of vancomycin guideline compliance', Melbourne, Australia, presented at ASCEPT-MPGPCR Joint Scientific Meeting, Melbourne, Australia, 27 November 2016 - 30 November 2016
,2009, 'Do divalent cations increase the anion-cation permeability in glycine receptor channels, even with initial offset and activity corrections?', Japan, pp. 393 - 393, presented at 36th International Congress of Physiological Sciences, Kyoto, Japan, 27 July 2009 - 01 August 2009
,2009, 'Molecular determinants of ion permeation in glycine receptor-channels: characterising charged residues in the intracellular M3-M4 loop', Kyoto, Japan, Vol. 59, pp. 393 - 393, presented at 36th International Congress of Physiological Societies, Kyoto, Japan, 27 July 2009 - 01 August 2009
,